Author

S. G. Abbasova

Observed names: S. Abbasova, Аббасова С.Г.

Institution: Generium Pharmaceuticals (Russia)

Observed institution: Generium Pharmaceuticals (Russia)

ORCID: 0000-0001-5841-7587

Observed ORCID: 0000-0001-5841-7587

OpenAlex ID: A5071080340

Assessment of T-cell immunity to SARS-CoV-2 in COVID-19 convalescents and vaccinated subjects, using TigraTest® SARS-CoV-2 ELISPOT kit

2021 · D. A. Poteryaev, S. G. Abbasova, et al. · Biological Products Prevention Diagnosis Treatment · 15

A Study of the Comparability of the Pharmacodynamic, Toxicological, and Pharmacokinetic Properties of the Reference Drug Pulmozyme® and the Biosimilar Drug Tigerase®

2024 · M. S. Aksenova, E. N. Bocharova, et al. · Doklady Biochemistry and Biophysics · 3

Comparability of the Reference Drug Pulmozim and a Similar Drug Tigerase in Terms of their Pharmacodynamic, Toxicological and Pharmacokinetic Properties

2023 · M. S. Aksenova, E. N. Bocharova, et al. · Journal Biomed · 2

Method development and validation for determination of antihemolytic activity of eculizumab (Soliris)

2016 · E. Yu. Prudnikova, G. N. Poroshin, et al. · Pharmacy & Pharmacology · 2

Validation of an Analytical Procedure for Evaluating the Biological Activity of a Medicinal Product Based on Tocilizumab and Determination of Acceptance Criteria for Test Results

2024 · Yu. A. Nikonova, S. G. Abbasova, et al. · Ведомости Научного центра экспертизы средств медицинского применения · 1

Сопоставимость функциональных свойств разрабатываемого биоаналогичного препарата GNR-069 и референтного лекарственного препарата Энплейт® in vitro

2023 · S. Abbasova, O. Strizhakova, et al. · Биофармацевтический журнал

Internalization of Recombinant Imiglucerase into Mouse Peritoneal Macrophages and L929 Mouse Fibroblasts

2020 · I. V. Lyagoskin, M. S. Pantyushenko, et al. · Biological Products Prevention Diagnosis Treatment

Works count: 8

Citation count: 23

H-index: 2

I10-index: 1